[1]Locationinpatent:experimentalpartHutinec,Antun;Rupcic,Renata;Ziher,Dinko;Smith,KirstenS.;Milhous,Wilbur;Ellis,William;Ohrt,Colin;Schoenfeld,ZrinkaIvezic[BioorganicandMedicinalChemistry,2011,vol.19,#5,p.1692-1701]
185300-51-0
923113-32-0
87131-15-5
384855-46-3 | 3-Nitro-4-[(3-pyridinylmethyl)amino]benzoic acid | AA00C8JV | MFCD02221224
396102-17-3 | (2,3-Dimethoxy-5-methylphenyl)boronic acid | AA00C8OH | MFCD12827469
401589-18-2 | 2-Amino-n-cyclooctylbenzamide | AA00C8T0 | MFCD03015444
340312-91-6 | 4-(2,5-Dimethyl-1H-pyrrol-1-yl)-3-methylbenzoic acid | AA00C8X5 | MFCD18820553
40232-88-0 | 4-Benzyloxy-3-methoxyphenol | AA00C93C | MFCD11655887
3926-64-5 | 2-hydroxypromazine | AA00C989 | MFCD01706904
344768-30-5 | cis-1-(Phenanthrene-3-carbonyl)-piperazine-2,3-dicarboxylic Acid | AA00C9FQ | MFCD29045520
425702-95-0 | 6-(Trifluoromethyl)-[1,2,4]triazolo[4,3-a]pyridin-3(2h)-one | AA00C9KH | MFCD23701113
31595-32-1 | t-Butyl 2-pyridyl ketone | AA00C9RT | MFCD06738273
345931-85-3 | 1-[2-Hydroxy-3-(1-naphthalenyloxy)propyl]-2,5-pyrrolidinedione | AA00C9YX | MFCD00527429